Cohort study describes clinical and treatment profiles in patients with idiopathic inflammatory myopathy, highlighting their response to rituximab.
This study was designed with the aim to describe the clinical phenotype, serological and radiological profiles and treatment response to rituximab in patients with idiopathic inflammatory myositis (IIM) in a Pakistani population.
No takes yet. Share an insight, caveat, or question.
Aziz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: